Medfinder
Back to blog

Updated: March 11, 2026

Emverm Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Emverm Shortage Update: What Patients Need to Know in 2026

Is Emverm still in shortage in 2026? Get the latest update on Mebendazole availability, pricing, alternatives, and how to find it at a pharmacy near you.

Emverm in 2026: What's the Latest on Availability?

If you've been prescribed Emverm (Mebendazole) and can't find it at your pharmacy, you're not imagining things. Emverm has faced persistent availability challenges for years, and 2026 is no different. While the drug isn't always listed on the FDA's official drug shortage database, the reality on the ground tells a different story — many patients are struggling to get their prescriptions filled.

In this update, we'll cover where things stand right now, why Emverm remains hard to find, what it costs in 2026, and what you can do about it.

Is Emverm Still in Shortage?

Emverm's availability situation is complicated. As of early 2026, Mebendazole is not always formally listed as a drug in shortage by the FDA or ASHP (American Society of Health-System Pharmacists). However, patients and pharmacists consistently report difficulty obtaining it.

The issue isn't a traditional manufacturing shortage — it's a distribution and access problem. Emverm is manufactured by Amneal Pharmaceuticals, and production continues. But the drug's extremely high cost and low prescription volume mean most pharmacies don't keep it in stock. The result feels like a shortage to patients even when supply technically exists in the distribution system.

Why Is Emverm Still Hard to Find?

Several factors continue to limit access in 2026:

Single-Source Manufacturing

Emverm is the only FDA-approved Mebendazole product in the United States. The original brand, Vermox, was discontinued in 2011, and no generic version has been approved since. This means any disruption in Amneal's supply chain directly impacts every patient who needs the drug.

Extreme Pricing

A single Emverm 100 mg chewable tablet costs approximately $638 at retail. A full 3-day treatment course (6 tablets) can cost $3,900 to $4,340 without insurance. These prices discourage pharmacies from stocking the drug, since unsold inventory ties up thousands of dollars.

Low Demand Creates a Vicious Cycle

Worm infections are relatively uncommon in the US, so pharmacies process only a handful of Emverm prescriptions per year. This low demand means pharmacies don't stock it, which makes it harder for patients to find, which makes it look like there's even less demand — and the cycle continues.

Insurance Barriers

Many insurance plans require prior authorization for Emverm, adding days of delay. Some plans use step therapy, requiring patients to try over-the-counter Pyrantel Pamoate first. Others place Emverm on high-cost specialty tiers with significant copays.

What Does Emverm Cost in 2026?

Here's a breakdown of current pricing:

  • Cash price (no insurance): $638 per tablet, or $3,900-$4,340 for a 6-tablet course
  • With the Emverm Savings Program: As low as $5 out-of-pocket (max savings of $80 per prescription)
  • With insurance: Varies widely — from $0 to several hundred dollars depending on your plan's formulary and tier placement
  • Patient Assistance Program: Free medication for qualifying patients through Amneal's PAP

For detailed information on reducing your costs, read our guide on how to save money on Emverm in 2026.

Are There New Options in 2026?

As of early 2026, there are no new FDA-approved Mebendazole products or generics on the horizon. However, patients do have established alternatives:

  • Albendazole (Albenza): A prescription benzimidazole anthelmintic with similar effectiveness. Cash price around $480-$545 for a course. Generic versions available.
  • Pyrantel Pamoate (Pin-X, Reese's): Available over the counter for $8-$15. Effective primarily for pinworm.
  • Ivermectin (Stromectol): Prescription antiparasitic, available in generic form. Effective for roundworm and other parasites.

For a full comparison, see our article on alternatives to Emverm.

How to Find Emverm in Stock

If you need Emverm specifically, here's your best approach:

1. Search Online First

Use Medfinder to search for pharmacies near you that currently have Emverm in stock. This is faster and more reliable than calling around randomly.

2. Try Independent Pharmacies

Independent pharmacies are more likely to special-order Emverm and often receive shipments within 24-48 hours. They're typically more flexible than chain pharmacies when it comes to sourcing hard-to-find medications.

3. Ask Your Pharmacy to Order It

Even if a pharmacy doesn't stock Emverm, most can order it from their distributor. Expect 1-2 business days for delivery. Place the order early in the week for the fastest turnaround.

4. Contact Your Doctor for Help

Your prescriber's office may be able to contact specialty pharmacies or distributor representatives directly. If Emverm truly isn't available, they can prescribe an alternative. Find out more about finding a doctor who prescribes Emverm.

For a complete walkthrough, read our guide on how to find Emverm in stock near you.

Final Thoughts

The Emverm availability picture in 2026 hasn't changed dramatically from recent years. The drug isn't in a formal shortage, but real-world access remains limited due to high pricing, single-source manufacturing, and low pharmacy stocking rates. The key for patients is to be proactive: use tools like Medfinder, explore independent pharmacies, take advantage of the Emverm Savings Program, and keep your doctor in the loop.

Worm infections — especially pinworm — are treatable and shouldn't be delayed. If you can't find Emverm right away, talk to your doctor about alternatives so you can start treatment as soon as possible.

Healthcare providers can learn more about helping their patients in our provider shortage briefing and provider's guide to finding Emverm.

Frequently Asked Questions

Emverm is not consistently listed on the FDA's formal drug shortage database. However, patients routinely have difficulty finding it at pharmacies due to high cost, single-source manufacturing, and low stocking rates. The practical effect is similar to a shortage.

As of early 2026, there are no FDA-approved generic versions of Emverm (Mebendazole) in the US, and none have been publicly announced as imminent. The original Vermox brand was discontinued in 2011, and Emverm remains the only option.

The retail cash price for Emverm is approximately $638 per 100 mg tablet, or $3,900-$4,340 for a full 6-tablet course. The Emverm Savings Program can reduce your cost to as low as $5 per prescription, and the Amneal Patient Assistance Program provides free medication for qualifying patients.

Yes. Common alternatives include Albendazole (Albenza), a prescription anthelmintic with similar effectiveness, and Pyrantel Pamoate, which is available over the counter for pinworm infections at $8-$15. Your doctor can recommend the best option based on your specific infection type.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

30,895 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,895 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?